Full Press Release Details
Inclusion Marks Another Milestone as Trulieve Broadens U.S. Capital Markets Exposure
TALLAHASSEE, Fla., Sept. 22, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company has been added to the S&P Total Market Index (TMI), S&P Completion Index (CI), and sector sub-indices S&P TMI Health Care and S&P CI Health Care.
"Trulieve's addition to S&P indices represents another important step forward following Trulieve's listing on the New York Stock Exchange and domestication to the U.S.," said Trulieve Chief Executive Officer Kim Rivers. "Index inclusion raises visibility for Trulieve, ultimately improving liquidity and attracting new institutional investors."
The S&P TMI is one of the broadest equity benchmarks published by S&P Dow Jones Indices, encompassing a wide range of U.S. companies that meet eligibility criteria. The S&P CI includes the S&P TMI minus the S&P 500.
About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.
Facebook: @Trulieve Instagram: @Trulieve X: @Trulieve